4-(1,2,3-Thiadiazol-4-yl)benzamide

Catalog No.: 
ACZMSO127
CAS No.: 
175205-53-5
Molecular Formula: 
C9H7N3OS
Molecular Weight: 
205.24
4-(1,2,3-Thiadiazol-4-yl)benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$234.00InquiryInquiry
250mg95%$365.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(1,2,3-Thiadiazol-4-yl)benzamide
IUPAC Name4-(1,2,3-thiadiazol-4-yl)benzamide
Molecular FormulaC9H7N3OS
Molecular Weight205.24
SMILESO=C(N)C1=CC=C(C2=CSN=N2)C=C1
InChI KeyPAVNUEROKSNSDS-UHFFFAOYSA-N
Synonym4-(1,2,3-THIADIAZOL-4-YL)BENZAMIDE;4-(1,2,3-thiadiazol-4-yl)benzamide, 95+%;Benzamide, 4-(1,2,3-thiadiazol-4-yl)-
CAS No.175205-53-5
PubChem CID2739359

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACZMSO127 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZMSO127 route product structure diagram
    ACZMSO127175205-53-5
Inquiry

2. ACZMSO127 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACZMSO127 route product structure diagram
    ACZMSO127175205-53-5
Inquiry

3. ACZMSO127 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEBJA798 route compound structure diagram
    ACEBJA798123088-59-5In Stock
  4. Then
  5. ACZMSO127 route product structure diagram
    ACZMSO127175205-53-5
Inquiry

Comments (0)